CCPE

CCPE estimates cell cycle pseudotime and identifies cell cycle phases from single-cell RNA-seq (scRNA-seq) data to characterize timing and progression of cellular events.


Key Features:

  • Pseudotime Estimation: Maps continuous progression of cells through the cell cycle using pseudotime analysis on scRNA-seq data.
  • Discriminative Helix Model: Represents the circular nature of the cell cycle with a discriminative helix model to estimate cyclic pseudotime.
  • Robustness to Dropout Events: Maintains performance in the presence of scRNA-seq dropout events to support phase identification from sparse data.
  • Identification of Cell Cycle Marker Genes: Identifies marker genes associated with distinct cell cycle stages for annotation of cell states.
  • Performance Evaluation: Evaluated on simulated and real scRNA-seq datasets to assess accuracy and competitiveness with existing methods.

Scientific Applications:

  • Cell cycle effect correction: Enables removal of cell cycle–associated variation from scRNA-seq data to reveal other biological signals.
  • Temporal dynamics analysis: Characterizes timing of gene expression in developmental biology, cancer progression, and stem cell differentiation studies.
  • Cell state annotation: Supports assignment of cell cycle phases and annotation of cell states via detected marker genes.

Methodology:

Discriminative helix model for circular representation of the cell cycle; pseudotime estimation of cellular progression; robustness to scRNA-seq dropout events; evaluation on simulated and real scRNA-seq datasets.

Topics

Details

License:
Not licensed
Cost:
Free of charge
Tool Type:
command-line tool
Operating Systems:
Mac, Linux, Windows
Programming Languages:
MATLAB, R, Python
Added:
6/2/2022
Last Updated:
6/2/2022

Operations

Publications

Liu J, Yang M, Zhao W, Zhou X. CCPE: cell cycle pseudotime estimation for single cell RNA-seq data. Nucleic Acids Research. 2021;50(2):704-716. doi:10.1093/nar/gkab1236. PMID:34931240. PMCID:PMC8789092.

PMID: 34931240
PMCID: PMC8789092
Funding: - National Institutes of Health: R01CA241930, R01GM123037, U01AR069395-01A1